Evidence map›Paper›PMID 15657432›Full record

ArticleMolecular and cellular biology2005

c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha.

Harish Srinivas, Denise M Juroske, Shailaja Kalyankrishna, Dianna D Cody, Roger E Price, Xiao-Chun Xu, Ramesh Narayanan, Nancy L Weigel, Jonathan M Kurie

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 68 citations in OpenAlex.

  1. Retinoic acid in health and disease.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Cocaine induces nuclear export and degradation of neuronal retinoid X receptor-γ via a TNF-α/JNK- mediated mechanism.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2015
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Harish SrinivasDepartment of Thoracic/Head and Neck Oncology-Unit 432, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
Denise M Juroske
Shailaja Kalyankrishna
Dianna D Cody
Roger E Price
Xiao-Chun Xu
Ramesh Narayanan
Nancy L Weigel
Jonathan M Kurie
The University of Texas MD Anderson Cancer Center · USBaylor College of Medicine · US

Funding

MOUSE MODELS OF LUNG CANCERSU01CA084306 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI JACKS, TYLER E. · 1999 to 2013
$12.0M
RETINOID SIGNALING IN NEW LUNG CANCER PREVENTION MODELSR01CA080686 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI KURIE, JONATHAN M · 2000 to 2005
$1.2M
NCI NIH HHS R01 CA080686NCI NIH HHS R01 CA 80686NCI NIH HHS U01 CA084306NCI NIH HHS U01 CA 84306
6 · The paper itself

Abstract

Retinoic acid (RA) is the ligand for nuclear RA receptors (RARs and RXRs) and is crucial for normal epithelial cell growth and differentiation. During malignant transformation, human bronchial epithelial cells acquire a block in retinoid signaling caused in part by a transcriptional defect in RARs. Here, we show that activation of c-Jun N-terminal kinase (JNK) contributes to RAR dysfunction by phosphorylating RARalpha and inducing degradation through the ubiquitin-proteasomal pathway. Analysis of RARalpha mutants and phosphopeptide mapping revealed that RARalpha residues Thr181, Ser445, and Ser461 are phosphorylated by JNK. Mutation of these residues to alanines prevented efficient ubiquitination of RARalpha and increased the stability of the protein. We investigated the importance of RARalpha phosphorylation by JNK as a mediator of retinoid resistance in lung cancer. Mice that develop lung cancer from activation of a latent K-ras oncogene had high intratumoral JNK activity and low RARalpha levels and were resistant to treatment with an RAR ligand. JNK inhibition in a human lung cancer cell line enhanced RARalpha levels, ligand-induced activity of RXR-RAR dimers, and growth inhibition by RA. These findings point to JNK as a key mediator of aberrant retinoid signaling in lung cancer cells.

Indexed as

3T3 CellsAnimalsChlorocebus aethiopsCOS CellsGenes, rasHeLa CellsHumansJNK Mitogen-Activated Protein KinasesLung NeoplasmsMiceMice, TransgenicMutationPhosphorylationProteasome Endopeptidase ComplexReceptors, Retinoic AcidRetinoic Acid Receptor alphaJNK Mitogen-Activated Protein KinasesProteasome Endopeptidase ComplexRARA protein, humanRara protein, mouseReceptors, Retinoic AcidRetinoic Acid Receptor alphaTretinoinUbiquitin

Identifiers

PMID15657432
PMCPMC543999
OpenAlexW2141745343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.